Funding for this research was provided by:
AbbVie
Astellas Pharma US
Biogen
Bristol-Myers Squibb
Continuum Clinical
Janssen Pharmaceuticals
Genentech
Merck
Novartis Pharmaceuticals Corporation
Otsuka America Pharmaceutical
Pfizer
PRA International
Article History
Received: 28 October 2020
Accepted: 19 May 2021
First Online: 7 June 2021
Declarations
:
: No potential conflicts were declared.